Evidence map›Paper›PMID 33557238›Full record

ArticleMedical sciences (Basel, Switzerland)2021

COVID-19 Management in a UK NHS Foundation Trust with a High Consequence Infectious Diseases Centre: A Retrospective Analysis.

Kenneth F Baker, Aidan T Hanrath, Ina Schim van der Loeff, Su Ann Tee, Richard Capstick, Gabriella Marchitelli, Ang Li, Andrew Barr, Alsafi Eid, Sajeel Ahmed and 17 more

Open access · goldAbstract read
In one paragraph

Article in Medical sciences (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 9 pooled it
2.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 9 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 3 institutions in 1 country.

Kenneth F BakerTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.ORCID 0000-0002-6735-2911
Aidan T HanrathTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Ina Schim van der LoeffTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Su Ann TeeThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UK.
Richard CapstickThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UK.
Gabriella MarchitelliThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UK.ORCID 0000-0003-2442-0547
Ang LiThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UK.
Andrew BarrThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UK.ORCID 0000-0002-8084-7644
Alsafi EidThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UK.
Sajeel AhmedThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UK.ORCID 0000-0002-0212-3704
Dalvir BajwaThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UK.
Omer MohammedThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UK.
Neil AldersonThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UK.
Clare LendremNIHR In Vitro Diagnostics Cooperative, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.ORCID 0000-0002-9435-7398
Dennis W LendremNational Institute of Health Research (NIHR) Newcastle Biomedical Research Centre, Newcastle University and The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE2 4HH, UK.ORCID 0000-0001-6268-5509
Covid-Control Group
Covid-Clinical Group
Lucia Pareja-CebrianThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UK.
Andrew WelchThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UK.
Joanne FieldThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UK.
Brendan A I PayneTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Yusri TahaThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UK.
David A PriceThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UK.
Christopher GibbinsThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UK.
Matthias L SchmidThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UK.
Ewan HunterThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UK.
Christopher J A DuncanTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Newcastle upon Tyne Hospitals NHS Foundation Trust · GBNewcastle University · GBNIHR Leeds In Vitro Diagnostics Co-operative · GB

Funding

Department of Health CL-2017-01-004Wellcome Trust 109975/Z/15/ZWellcome Trust 203105/Z/16/ZWellcome Trust 211153/Z/18/Z
6 · The paper itself

Abstract

Recent large national and international cohorts describe the baseline characteristics and outcome of hospitalised patients with COVID-19, however there is limited granularity to these reports. We aimed to provide a detailed description of a UK COVID-19 cohort, focusing on management and outcome. We performed a retrospective single-centre analysis of clinical management and 28-day outcomes of consecutive adult inpatients with SARS-CoV-2 PCR-confirmed COVID-19 from 31 January to 16 April 2020 inclusive. In total, 316 cases were identified. Most patients were elderly (median age 75) with multiple comorbidities. One quarter were admitted from residential or nursing care. Mortality was 84 out of 316 (26.6%). Most deaths occurred in patients in whom a ceiling of inpatient treatment had been determined and for whom end of life care and specialist palliative care input was provided where appropriate. No deaths occurred in patients aged under 56 years. Decisions to initiate respiratory support were individualised after consideration of patient wishes, premorbid frailty and comorbidities. In total, 59 (18%) patients were admitted to intensive care, of which 31 (10% overall cohort) required intubation. Multiple logistic regression identified associations between death and age, frailty, and disease severity, with age as the most significant factor (odds ratio 1.07 [95% CI 1.03-1.10] per year increase,

Indexed as

Outcome Assessment, Health CareAcademic Medical CentersAgedAged, 80 and overAge FactorsCOVID-19FemaleHospitalizationHumansMaleMiddle AgedState MedicineTertiary Care CentersUnited KingdomintubationmortalitySARS-CoV-2treatment escalationventilation

Identifiers

PMID33557238
PMCPMC7931073
OpenAlexW3128267370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.